What If the Peptide Shows No Effect in Your Vascular Injury Model
ET Saturday, June 6 DALLAS, JUNE 6, 2026 Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association , an open-access, peer-reviewed journal of the American Heart Association
Nevertheless, research findings across these diseases are inconsistent, highlighting the complexity of host-microbiota interactions (172)
It also slows gastric emptying , meaning food stays in your stomach longer, helping you feel fuller for an extended period
A.ShoemakerJ
Psychiatry Res (2020) 290:113163